Carbylan Therapeutics, Inc. 4
4 · Carbylan Therapeutics, Inc. · Filed Nov 4, 2015
Insider Transaction Report
Form 4
McKune John
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2015-11-02+50,000→ 50,000 totalExercise: $4.01Exp: 2025-11-02→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option shall vest with respect to one-quarter of the underlying shares upon the first anniversary of the vesting commencement date of August 5, 2015, and then with respect to the remaining shares monthly thereafter over the next three years.